Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications
{{output}}
Prostate cancer is the most common malignancy in men. Although frequently diagnosed at localized stages, a substantial proportion present high-risk features associated with biochemical recurrence and progression. In non-metastatic hormone-sensitive prostate ca... ...
